IBDEI17E ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,19553,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19553,1,3,0)
;;=3^Hemiplga fol ntrm intcrbl hemor aff right dominant side
;;^UTILITY(U,$J,358.3,19553,1,4,0)
;;=4^I69.151
;;^UTILITY(U,$J,358.3,19553,2)
;;=^5007441
;;^UTILITY(U,$J,358.3,19554,0)
;;=I69.152^^67^877^39
;;^UTILITY(U,$J,358.3,19554,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19554,1,3,0)
;;=3^Hemiplga fol ntrm intcrbl hemor aff left dominant side
;;^UTILITY(U,$J,358.3,19554,1,4,0)
;;=4^I69.152
;;^UTILITY(U,$J,358.3,19554,2)
;;=^5007442
;;^UTILITY(U,$J,358.3,19555,0)
;;=I69.153^^67^877^42
;;^UTILITY(U,$J,358.3,19555,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19555,1,3,0)
;;=3^Hemiplga fol ntrm intcrbl hemor aff right nondom side
;;^UTILITY(U,$J,358.3,19555,1,4,0)
;;=4^I69.153
;;^UTILITY(U,$J,358.3,19555,2)
;;=^5007443
;;^UTILITY(U,$J,358.3,19556,0)
;;=I69.154^^67^877^40
;;^UTILITY(U,$J,358.3,19556,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19556,1,3,0)
;;=3^Hemiplga fol ntrm intcrbl hemor aff left nondom side
;;^UTILITY(U,$J,358.3,19556,1,4,0)
;;=4^I69.154
;;^UTILITY(U,$J,358.3,19556,2)
;;=^5007444
;;^UTILITY(U,$J,358.3,19557,0)
;;=I69.851^^67^877^47
;;^UTILITY(U,$J,358.3,19557,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19557,1,3,0)
;;=3^Hemiplga fol oth cerebvasc disease aff right dominant side
;;^UTILITY(U,$J,358.3,19557,1,4,0)
;;=4^I69.851
;;^UTILITY(U,$J,358.3,19557,2)
;;=^5007535
;;^UTILITY(U,$J,358.3,19558,0)
;;=I69.852^^67^877^48
;;^UTILITY(U,$J,358.3,19558,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19558,1,3,0)
;;=3^Hemiplga fol oth cerebvasc disease aff left dominant side
;;^UTILITY(U,$J,358.3,19558,1,4,0)
;;=4^I69.852
;;^UTILITY(U,$J,358.3,19558,2)
;;=^5007536
;;^UTILITY(U,$J,358.3,19559,0)
;;=I69.853^^67^877^49
;;^UTILITY(U,$J,358.3,19559,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19559,1,3,0)
;;=3^Hemiplga fol oth cerebvasc disease aff right nondom side
;;^UTILITY(U,$J,358.3,19559,1,4,0)
;;=4^I69.853
;;^UTILITY(U,$J,358.3,19559,2)
;;=^5007537
;;^UTILITY(U,$J,358.3,19560,0)
;;=I69.854^^67^877^50
;;^UTILITY(U,$J,358.3,19560,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19560,1,3,0)
;;=3^Hemiplga fol oth cerebvasc disease aff left nondom side
;;^UTILITY(U,$J,358.3,19560,1,4,0)
;;=4^I69.854
;;^UTILITY(U,$J,358.3,19560,2)
;;=^5007538
;;^UTILITY(U,$J,358.3,19561,0)
;;=I69.251^^67^877^51
;;^UTILITY(U,$J,358.3,19561,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19561,1,3,0)
;;=3^Hemiplga fol oth ntrm intcrn hemor aff right dominant side
;;^UTILITY(U,$J,358.3,19561,1,4,0)
;;=4^I69.251
;;^UTILITY(U,$J,358.3,19561,2)
;;=^5007473
;;^UTILITY(U,$J,358.3,19562,0)
;;=I69.252^^67^877^52
;;^UTILITY(U,$J,358.3,19562,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19562,1,3,0)
;;=3^Hemiplga fol oth ntrm intcrn hemor aff left dominant side
;;^UTILITY(U,$J,358.3,19562,1,4,0)
;;=4^I69.252
;;^UTILITY(U,$J,358.3,19562,2)
;;=^5007474
;;^UTILITY(U,$J,358.3,19563,0)
;;=I69.253^^67^877^53
;;^UTILITY(U,$J,358.3,19563,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19563,1,3,0)
;;=3^Hemiplga fol oth ntrm intcrn hemor aff right nondom side
;;^UTILITY(U,$J,358.3,19563,1,4,0)
;;=4^I69.253
;;^UTILITY(U,$J,358.3,19563,2)
;;=^5007475
;;^UTILITY(U,$J,358.3,19564,0)
;;=I69.254^^67^877^54
;;^UTILITY(U,$J,358.3,19564,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19564,1,3,0)
;;=3^Hemiplga fol oth ntrm intcrn hemor aff left nondom side
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI17E 3826 printed Sep 23, 2025@19:39:12 Page 2
IBDEI17E ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,19553,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,19553,1,3,0)
+4 ;;=3^Hemiplga fol ntrm intcrbl hemor aff right dominant side
+5 ;;^UTILITY(U,$J,358.3,19553,1,4,0)
+6 ;;=4^I69.151
+7 ;;^UTILITY(U,$J,358.3,19553,2)
+8 ;;=^5007441
+9 ;;^UTILITY(U,$J,358.3,19554,0)
+10 ;;=I69.152^^67^877^39
+11 ;;^UTILITY(U,$J,358.3,19554,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,19554,1,3,0)
+14 ;;=3^Hemiplga fol ntrm intcrbl hemor aff left dominant side
+15 ;;^UTILITY(U,$J,358.3,19554,1,4,0)
+16 ;;=4^I69.152
+17 ;;^UTILITY(U,$J,358.3,19554,2)
+18 ;;=^5007442
+19 ;;^UTILITY(U,$J,358.3,19555,0)
+20 ;;=I69.153^^67^877^42
+21 ;;^UTILITY(U,$J,358.3,19555,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,19555,1,3,0)
+24 ;;=3^Hemiplga fol ntrm intcrbl hemor aff right nondom side
+25 ;;^UTILITY(U,$J,358.3,19555,1,4,0)
+26 ;;=4^I69.153
+27 ;;^UTILITY(U,$J,358.3,19555,2)
+28 ;;=^5007443
+29 ;;^UTILITY(U,$J,358.3,19556,0)
+30 ;;=I69.154^^67^877^40
+31 ;;^UTILITY(U,$J,358.3,19556,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,19556,1,3,0)
+34 ;;=3^Hemiplga fol ntrm intcrbl hemor aff left nondom side
+35 ;;^UTILITY(U,$J,358.3,19556,1,4,0)
+36 ;;=4^I69.154
+37 ;;^UTILITY(U,$J,358.3,19556,2)
+38 ;;=^5007444
+39 ;;^UTILITY(U,$J,358.3,19557,0)
+40 ;;=I69.851^^67^877^47
+41 ;;^UTILITY(U,$J,358.3,19557,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,19557,1,3,0)
+44 ;;=3^Hemiplga fol oth cerebvasc disease aff right dominant side
+45 ;;^UTILITY(U,$J,358.3,19557,1,4,0)
+46 ;;=4^I69.851
+47 ;;^UTILITY(U,$J,358.3,19557,2)
+48 ;;=^5007535
+49 ;;^UTILITY(U,$J,358.3,19558,0)
+50 ;;=I69.852^^67^877^48
+51 ;;^UTILITY(U,$J,358.3,19558,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,19558,1,3,0)
+54 ;;=3^Hemiplga fol oth cerebvasc disease aff left dominant side
+55 ;;^UTILITY(U,$J,358.3,19558,1,4,0)
+56 ;;=4^I69.852
+57 ;;^UTILITY(U,$J,358.3,19558,2)
+58 ;;=^5007536
+59 ;;^UTILITY(U,$J,358.3,19559,0)
+60 ;;=I69.853^^67^877^49
+61 ;;^UTILITY(U,$J,358.3,19559,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,19559,1,3,0)
+64 ;;=3^Hemiplga fol oth cerebvasc disease aff right nondom side
+65 ;;^UTILITY(U,$J,358.3,19559,1,4,0)
+66 ;;=4^I69.853
+67 ;;^UTILITY(U,$J,358.3,19559,2)
+68 ;;=^5007537
+69 ;;^UTILITY(U,$J,358.3,19560,0)
+70 ;;=I69.854^^67^877^50
+71 ;;^UTILITY(U,$J,358.3,19560,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,19560,1,3,0)
+74 ;;=3^Hemiplga fol oth cerebvasc disease aff left nondom side
+75 ;;^UTILITY(U,$J,358.3,19560,1,4,0)
+76 ;;=4^I69.854
+77 ;;^UTILITY(U,$J,358.3,19560,2)
+78 ;;=^5007538
+79 ;;^UTILITY(U,$J,358.3,19561,0)
+80 ;;=I69.251^^67^877^51
+81 ;;^UTILITY(U,$J,358.3,19561,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,19561,1,3,0)
+84 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff right dominant side
+85 ;;^UTILITY(U,$J,358.3,19561,1,4,0)
+86 ;;=4^I69.251
+87 ;;^UTILITY(U,$J,358.3,19561,2)
+88 ;;=^5007473
+89 ;;^UTILITY(U,$J,358.3,19562,0)
+90 ;;=I69.252^^67^877^52
+91 ;;^UTILITY(U,$J,358.3,19562,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,19562,1,3,0)
+94 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff left dominant side
+95 ;;^UTILITY(U,$J,358.3,19562,1,4,0)
+96 ;;=4^I69.252
+97 ;;^UTILITY(U,$J,358.3,19562,2)
+98 ;;=^5007474
+99 ;;^UTILITY(U,$J,358.3,19563,0)
+100 ;;=I69.253^^67^877^53
+101 ;;^UTILITY(U,$J,358.3,19563,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,19563,1,3,0)
+104 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff right nondom side
+105 ;;^UTILITY(U,$J,358.3,19563,1,4,0)
+106 ;;=4^I69.253
+107 ;;^UTILITY(U,$J,358.3,19563,2)
+108 ;;=^5007475
+109 ;;^UTILITY(U,$J,358.3,19564,0)
+110 ;;=I69.254^^67^877^54
+111 ;;^UTILITY(U,$J,358.3,19564,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,19564,1,3,0)
+114 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff left nondom side
